The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR-ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples